Topiramate: a review of preclinical, pharmacokinetic, and clinical data.
about
Review of the use of Topiramate for treatment of psychiatric disordersSpecial considerations in the treatment of patients with bipolar disorder and medical co-morbiditiesGlutamatergic transmission in drug reward: implications for drug addictionHemicrania continua: side alternation and response to topiramateLow energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort studyPharmacotherapy of Obesity: Clinical Trials to Clinical Practice.The role of glutamate in anxiety and related disorders.Review of topiramate for the treatment of epilepsy in elderly patients.Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies.Paroxysmal hemicrania responding to topiramateTreatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study.Anticonvulsants in central pain.Central nervous system agents for ischemic stroke: neuroprotection mechanismsBilateral acute angle-closure glaucoma following treatment with topiramate for headache.New anticonvulsant medication uses in bipolar disorder.Role of topiramate for the treatment of painful diabetic peripheral neuropathy.Preventive treatment of migraine: effect on weight.Topiramate for the treatment of epilepsy and other nervous system disorders.Topiramate, pseudotumor cerebri, weight-loss and glaucoma: an ophthalmologic perspective.Role of valproate across the ages. Treatment of epilepsy in adults.Topiramate and type 2 diabetes: an old wine in a new bottle.Psychopharmacology of topiramate: from epilepsy to bipolar disorder.Acute topiramate differentially affects human aggressive responding at low vs. moderate doses in subjects with histories of substance abuse and antisocial behaviorPharmacotherapy of essential tremorEmerging drugs for obesity therapy.Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.Animal models of headache: from bedside to bench and back to bedside.Safety of topiramate for treating migraines.New molecular targets in the pathophysiology of obesity and available treatment options under investigation.Use of Antiepileptic Drugs in Patients with Chronic Kidney Disease and End Stage Renal Disease.Antioxidant activity of topiramate: an antiepileptic agent.Postmarketing Results: Useful, But Proceed with CautionPostmarketing experience with topiramate and cognition.Treatment of cluster headache with topiramate: effects and side-effects in five patients.Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet.A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity.Topiramate in the treatment of chronic migraine.SUNCT syndrome successfully treated with topiramate: case reports.Daytime sleepiness in epilepsy patients receiving topiramate monotherapy.Topiramate inhibits trigeminovascular neurons in the cat.
P2860
Q24523918-26410447-B92A-4D04-9B2C-B1417E8C39CFQ24806762-FA4ED4C7-B541-4534-91A6-683DB3988BD9Q28112161-37C29BA1-9F0F-461C-A2E4-45C1F0CB2512Q28296739-CCEA30EA-6CCB-4523-A5CF-A69A15D3D94BQ28750454-08037E30-E4D5-4C3D-8C9B-07CF647CCC22Q30400748-66BB251B-2786-4058-A6AE-F769BCF25BFFQ31029023-8A7D0BB2-CE0C-489E-B016-352E528E7F66Q33819386-43B82263-1AAF-4549-A804-A1262208B7E0Q34185330-92BEEBD2-7ACF-464E-A9B2-40C8012E0365Q34525299-F909BC5B-7FBB-45A3-9503-85AED09C0416Q34699512-7D140F19-B53D-4F71-82AE-A1118E03390FQ34974796-CAD7FB99-874F-4286-8A5A-1A80BC496CC7Q35137635-BA6BA593-556E-48AE-AA1A-8566152775ADQ35309277-CDC1C362-11E8-4280-B76B-A9B2367BE663Q35673095-6407D9EE-B2F9-4003-97A1-660CC980F469Q35906320-30276FEB-B85C-468D-B5C2-675D090FADAFQ35987931-387CA853-8ADE-477B-B9CF-4BEB8509FE2EQ36390841-A2E68EE4-8360-425E-A086-73324FE6FB90Q36414182-6D153B5A-D951-49C6-AE9E-B9F9ACE3376EQ36507535-DFBB4738-ADA3-499A-B8A1-593AB6CCA038Q37030881-14E52194-A689-4810-AFAF-B967DC9DB7BDQ37166152-7704B037-196B-4D50-BDC6-1569EA25A096Q37350134-207CEE45-A105-4B39-8D91-B7F0A37F5A4FQ37414979-6CD3DDAA-8034-436F-860F-A1EB2C6C70ADQ37494328-557032E6-EE13-4877-8FAD-524D3F99DEBBQ37507823-047D6951-4120-4826-9CFF-52B1BE683F69Q37699421-4119F86C-398F-444A-A920-74616D5D5FB3Q38237259-5353BAF6-1B0C-479A-90D4-EB8950B4D7D2Q38397535-90113E3B-5120-4860-9AB3-D1445A94D298Q38451960-36F92A33-0CDD-49C0-A1B0-48DE6B4C3F29Q39337872-3B6B9DE6-19B0-4154-810E-75D79A0E9CC8Q40467788-2C57B408-064D-4381-898E-3953C07E67A3Q42660595-950B1787-65EA-4213-9596-0831D8638297Q44016420-0F8B0C54-A110-4113-897A-A8B4720FAB85Q44169569-68942F43-7841-47DA-8001-054572C021B5Q44477346-3FE81765-550D-4FDF-982D-F2F39D7970EBQ44597128-0BF6815A-2BDF-4EE7-B798-E7C1DF074D8FQ44776570-EC326715-1689-4072-93D8-B55F837B80B1Q44805063-B248C74F-3177-48C9-9F7B-EF7A1985CA4FQ45164394-94191263-F814-44BB-8D0B-C8799604AFA5
P2860
Topiramate: a review of preclinical, pharmacokinetic, and clinical data.
description
1997 nî lūn-bûn
@nan
1997 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Topiramate: a review of preclinical, pharmacokinetic, and clinical data.
@ast
Topiramate: a review of preclinical, pharmacokinetic, and clinical data.
@en
type
label
Topiramate: a review of preclinical, pharmacokinetic, and clinical data.
@ast
Topiramate: a review of preclinical, pharmacokinetic, and clinical data.
@en
prefLabel
Topiramate: a review of preclinical, pharmacokinetic, and clinical data.
@ast
Topiramate: a review of preclinical, pharmacokinetic, and clinical data.
@en
P1476
Topiramate: a review of preclinical, pharmacokinetic, and clinical data.
@en
P2093
W E Rosenfeld
P304
P356
10.1016/S0149-2918(97)80006-9
P577
1997-11-01T00:00:00Z